Inhibition of PKD2 activation could significantly inhibit the expression of P-gp and decrease multiple drug resistance (MDR) in human breast cancer cells [38], indicating that PKD2 may be an important target for tumor biotherapy and MDR reversal. This evidence concerns the gene PKD2 and breast carcinoma.